BRCA1 and ovarian carcinoma: Furthermore, genetic counseling and testing for BRCA1/2 mutations should be offered to all newly diagnosed patients, as it was estimated that 18% of ovarian cancer cases were associated with germline mutations, mostly of the BRCA1/2 genes [6].